Twist Bioscience Corp vs Under Armour Inc Class A — how do they compare? Twist Bioscience Corp trades at $123 (market cap $7.72B), while Under Armour Inc Class A trades at $5.24 (market cap $2.26B). The key difference: Twist Bioscience Corp is far larger — about 3.4× Under Armour Inc Class A's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals.
| TWST | UA | |
|---|---|---|
Market Cap | $7.72B | $2.26B |
Sector | Health | Consumer Cyclical |
52-Week High | $124.88 | $7.88 |
52-Week Low | $24.16 | $3.96 |
Enterprise Value | $7.65B | $3.24B |
Trailing returns across standard periods
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →